Sahar M. Hussein

Sahar M. Hussein

Auto-generated profile, based on publicly available information

Sahar M. Hussein

Department of Molecular and Medical Biotechnology, College of Biotechnology, Al-Nahrain University, Baghdad, Iraq

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2026 in Archives of Breast Cancer
Verified
Journal Article
Open access
PDF file
SHSahar M. Hussein
Sahar M. Hussein
RARuaa Maan Attallah
Ruaa Maan Attallah
NHNoora A. Hadi
Noora A. Hadi
RARoya Al-Haddad
Roya Al-Haddad
Background: Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype for which reliable molecular biomarkers remain an important research need. We aimed to compare serum miR-21, miR-30, and miR-125 expression and tissue EGFR mRNA expression between TNBC cases and their respective control groups, and to explore biomarker correlations and apparent diagnostic discrimination.Methods: This hospital-based case-control study was conducted from April 2024 to November 2025. Among 105 women with histopathologically confirmed HER2-negative breast cancer, 32 patients with TNBC underwent molecular analysis. Serum miRNAs were compared with healthy female controls, whereas tumor-tissue EGFR mRNA was compared with histopathologically confirmed benign breast tissue because healthy breast tissue could not be obtained ethically. Expression was measured by reverse-transcription quantitative polymerase chain reaction. Group comparisons used ΔCt values; receiver operating characteristic (ROC) analyses used 2−ΔΔCt values and were exploratory and unvalidated.Results: Relative to their respective control groups, TNBC cases had higher miR-21 (4.30-fold) and tissue EGFR (6.69-fold) expression and lower miR-30 (0.02-fold) and miR-125 (0.13-fold) expression (all P < .001). In exploratory analyses restricted to TNBC participants, serum miR-30 and miR-125 were positively correlated (r = 0.601, P < .001, n = 30), meeting the Bonferroni-adjusted threshold; all other correlations were weak and nonsignificant. Apparent AUCs were 0.876 for miR-21, 1.000 for miR-30, 1.000 for miR-125, and 0.865 for EGFR; assay-specific ROC sample sizes ranged from 44 to 47 participants.Conclusion: Serum miRNA and tissue EGFR expression differed between TNBC cases and their distinct comparator groups. The markers were measured in different biological compartments, the cohort was small, reference genes were not validated for stability, and the ROC results were not validated internally or externally. Therefore, these results are exploratory and do not establish a combined clinical biomarker panel.

10 June 2026 in Ukrainian Journal of Nephrology and Dialysis
Verified
Journal Article
Open access
WNWurood N. Nayyfa
Wurood N. Nayyfa
SHSahar M. Hussein
Sahar M. Hussein
Urinary tract infection (UTI) is associated with inflammatory activation involving cytokines and microRNAs (miRNAs). However, the relationship between tumor necrosis factor-alpha (TNF-α), miRNA expression, immune cell profiles, and renal function remains unclear. The present study aimed to evaluate TNF-α, miR-125, and miR-155 expression in women with UTI and assess their association with immune cell profiles and kidney function. Methods. This cross-sectional study included 123 women with culture-confirmed UTI and 40 healthy controls. Hematological and biochemical parameters were measured, and expression levels of TNF-α, miR-125, and miR-155 were assessed using qRT-PCR. Correlation analysis was performed to evaluate associations between molecular markers, immune cell profiles, and kidney function. Results. TNF-α, miR-125, and miR-155 expression levels were all significantly higher in UTI patients compared with controls (all p < 0.05). TNF-α expression was positively correlated with miR-155 (r = 0.515, p = 0.01) and miR-125 (r = 0.459, p = 0.024), while a strong correlation was observed between miR-125 and miR-155 (r = 0.734, p < 0.0001). miR-125 was associated with lymphocytes (r = 0.545, p = 0.0058), eosinophils (r = 0.406, p = 0.049), and monocytes (r = 0.406, p = 0.049), while miR-155 was correlated with lymphocytes (r = 0.462, p = 0.023). No significant correlations were found between TNF-α or miRNAs and renal function markers (p > 0.05). Conclusions. TNF-α is associated with microRNA expression in UTI. microRNAs show stronger relationships with immune cell profiles, while neither TNF-α nor microRNAs is associated with kidney function.